Page 66 - Read Online
P. 66

Hou et al. Hepatoma Res 2023;9:35                               Hepatoma Research
               DOI: 10.20517/2394-5079.2023.40



               Opinion                                                                       Open Access



               Perspective of tumor heterogeneity for treatments of

               intrahepatic cholangiocarcinoma with intrahepatic
               lithiasis


                                                3
                                  2
                         1
               Wenjie Hou , Yifan Tu , Minghua Zheng , Qiqiang Zeng 4
               1
                Radiological Department, Wenzhou heping international hospital, WenZhou 325000, Zhejiang, China.
               2
                The First Clinical Medical College of Wenzhou Medical University, Wenzhou 325000, Zhejiang, China.
               3
                Department of Infection and Liver Diseases, Liver Research Center, the First Affiliated Hospital of Wenzhou, WenZhou 325000,
               Zhejiang, China.
               4
                Department of General Surgery, Wenzhou heping international hospital, WenZhou 325000, Zhejiang, China.
               Correspondence to: Prof. Qiqiang Zeng, Department of General Surgery, Wenzhou heping international hospital, 1919#ouyue
               road, WenZhou 325000, Zhejiang, China. E-mail: zengqiqiangwz@163.com
               How to cite this article: Hou W, Tu Y, Zheng M, Zeng Q. Perspective of tumor heterogeneity for treatments of
               intrahepatic cholangiocarcinoma with intrahepatic lithiasis. Hepatoma Res 2023;9:35. https://dx.doi.org/10.20517/2394-
               5079.2023.40
               Received: 8 May 2023  First Decision: 13 Jun 2023  Revised: 28 Jun 2023  Accepted: 25 Jul 2023  Published: 31 Jul 2023
               Academic Editors: Timothy M Pawlik, Giuliano Ramadori, Gabriele Missale  Copy Editor: Yanbing Bai  Production Editor:
               Yanbing Bai

               Abstract
               The  heterogeneity  of  tumors  results  in  significantly  distinct  biological  characteristics  of  intrahepatic
               cholangiocarcinoma (ICC) caused by different etiologies. Among them, ICC caused by intrahepatic lithiasis (IHL-
               ICC) presents challenges in early detection, tumor staging, and surgical treatment, and has the poorest prognosis
               among all etiologies of ICC patients. Thus, it is essential to focus on early assessment of the possibility of
               developing ICC, prompt intervention of intrahepatic lithiasis, anatomical resection of hepatic parenchyma
               corresponding to the branch of the intrahepatic bile duct undergoing cancerous transformation, and enhanced
               postoperative follow-up of hepatolithiasis and ICC for IHL-ICC patients. These interventions are crucial to improve
               the clinical outcomes and overall survival of IHL-ICC patients.

               Keywords: Intrahepatic cholangiocarcinoma, heterogeneity, etiology, intrahepatic lithiasis, early diagnosis,
               treatment, prognosis











                           © The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
                           adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
               long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
               indicate if changes were made.

                                                                                             www.hrjournal.net
   61   62   63   64   65   66   67   68   69   70   71